Yue Liu, MD

National Cancer Center CAMS & PUMC

Beijing, Beijing

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 27

1086 - PD-1/PD-L1 Blockade Added to First-Line Asparaginase-Based Chemotherapy with or without Radiotherapy in Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Retrospective Study from the CLCG

Room 162

05:15pm - 05:20pm ET

Sep 28

2791 - Immune Checkpoint Inhibitor Combined with Radiotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma: A Transplant-Free Retrospective Study

03:00pm - 04:00pm ET